An2 Therapeutics, Inc. · NASDAQ:ANTX
Williams Sarah Joanne sold 265 An2 Therapeutics, Inc. shares (Form 4)
Traded May 29, 2026 · Filed Jun 2, 2026
On May 29, 2026, Williams Sarah Joanne (Principal Accounting Officer) sold 265 An2 Therapeutics, Inc. shares at US$4.43 for US$1,174, leaving 66,583 shares. Filed Jun 2, 2026 (Form 4).
- Sold
- 265 shares
- Price
- US$4.43
- Value
- US$1,174
- Holding after
- 66,583 shares
- Trading plan
- No
- Role
- Principal Accounting Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 29, 2026 | Common Stock | Sale | 265 | US$4.43 | 66,583 | Direct |
Source
Related
- An2 Therapeutics, Inc.
- Williams Sarah Joanne
- An2 Therapeutics, Inc. shareholders
- Form 4 · Williams Sarah Joanne · Sep 4, 2026
- Form 4 · Aziz Kabeer · Oct 13, 2026
- Form 4 · Martin Patricia A. · Oct 13, 2026
- Form 4 · Marks Gilbert Lynn · Oct 13, 2026
- Form 4 · Trenor Cameron C. III · Sep 16, 2026
- Form 4 · Readnour Robin Shane · Sep 11, 2026